News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,529 Results
Type
Article (39433)
Company Profile (307)
Press Release (648789)
Section
Business (204789)
Career Advice (2004)
Deals (35475)
Drug Delivery (87)
Drug Development (80997)
Employer Resources (168)
FDA (16119)
Job Trends (14860)
News (345820)
Policy (32549)
Tag
Academia (2548)
Alliances (49433)
Alzheimer's disease (1235)
Approvals (16050)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11560)
Biotechnology (218)
Breast cancer (121)
Cancer (1092)
Cardiovascular disease (99)
Career advice (1672)
Cell therapy (236)
Clinical research (64379)
Collaboration (390)
Compensation (202)
COVID-19 (2546)
C-suite (95)
Data (1130)
Diabetes (153)
Diagnostics (6161)
Earnings (84950)
Employer resources (146)
Events (110003)
Executive appointments (310)
FDA (16661)
Funding (356)
Gene therapy (178)
GLP-1 (581)
Government (4339)
Healthcare (18689)
Infectious disease (2631)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16336)
Job creations (3659)
Job search strategy (1429)
Layoffs (417)
Legal (7888)
Lung cancer (170)
Manufacturing (178)
Medical device (13185)
Medtech (13190)
Mergers & acquisitions (19218)
Metabolic disorders (404)
Neuroscience (1513)
NextGen Class of 2024 (6535)
Non-profit (4477)
Northern California (1488)
Obesity (232)
Opinion (183)
Patents (102)
People (56597)
Phase I (20016)
Phase II (28366)
Phase III (21131)
Pipeline (458)
Postmarket research (2555)
Preclinical (8525)
Radiopharmaceuticals (236)
Rare diseases (220)
Real estate (5937)
Regulatory (21595)
Research institute (2316)
Resumes & cover letters (350)
Southern California (1308)
Startups (3614)
United States (13565)
Vaccines (551)
Weight loss (169)
Date
Today (19)
Last 7 days (653)
Last 30 days (3449)
Last 365 days (35800)
2024 (32884)
2023 (40177)
2022 (51287)
2021 (55837)
2020 (54158)
2019 (46647)
2018 (35125)
2017 (32222)
2016 (31629)
2015 (37707)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (192)
Asia (37335)
Australia (6108)
California (3355)
Canada (1296)
China (254)
Colorado (148)
Connecticut (153)
Europe (80007)
Florida (461)
Georgia (116)
Illinois (344)
Indiana (197)
Kansas (97)
Maryland (577)
Massachusetts (2625)
Michigan (158)
Minnesota (274)
New Jersey (957)
New York (965)
North Carolina (703)
Northern California (1488)
Ohio (141)
Pennsylvania (850)
South America (1094)
Southern California (1308)
Texas (470)
Utah (90)
Washington State (363)
688,529 Results for "shoreline biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SHORELINE BIOSCIENCES TO PRESENT AT 2024 STIFEL HEALTHCARE CONFERENCE
November 18, 2024
·
1 min read
Biotech Beach
Shoreline Biosciences to Participate at the 2023 Wedbush Pacgrow Healthcare Conference
Shoreline Biosciences, Inc., a biopharmaceutical company developing effective and differentiated cellular immunotherapies based on induced pluripotent stem cells derived natural killer cells and macrophages, announced that it will participate in the 2023 Wedbush Pacgrow Healthcare Conference taking place August 8-9, 2023 in New York, NY.
August 3, 2023
·
1 min read
Biotech Beach
Shoreline Biosciences Wins a Comprehensive Summary Judgement Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on IPSC Generation and Use
Shoreline Biosciences, Inc. announced a major milestone in its patent litigation with Fate Therapeutics, Inc. and the Whitehead Institute in the U.S. District Court for the Southern District of California.
September 7, 2023
·
2 min read
Deals
Editas Medicine and Shoreline Biosciences Enter into Definitive Agreement for Shoreline to Acquire Editas’ iNK Cell Franchise and Related Gene Editing Technologies
Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it has entered into a definitive agreement with Shoreline Biosciences (Shoreline) for Shoreline to license Editas Medicine’s proprietary SLEEK.
January 19, 2023
·
6 min read
Press Releases
Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
November 22, 2024
·
5 min read
Drug Development
Shoreline Biosciences Presents Data at AACR 2023 Demonstrating Novel Methodology to Produce Clinical Scale iPSC-derived NK (iNK) Cells
Shoreline Biosciences, Inc. (Shoreline) today announced the presentation of preclinical data at the American Association for Cancer Research (AACR) annual meeting taking place in Orlando, FL, from April 14-19, 2023.
March 16, 2023
·
1 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Biotech Beach
Shoreline Biosciences Announces Appointment of Mauro P. Avanzi, M.D., Ph.D., As Chief Medical Officer
Shoreline Biosciences, Inc. today announced the appointment of Mauro P. Avanzi , M.D., Ph.D. as Chief Medical Officer.
February 21, 2023
·
3 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
1 of 68,853
Next
